[1]
GUTTMACHER AF. Factors affecting normal expectancy of conception. Journal of the American Medical Association. 1956 Jun 30:161(9):855-60
[PubMed PMID: 13319020]
[2]
. Infertility Workup for the Women's Health Specialist: ACOG Committee Opinion, Number 781. Obstetrics and gynecology. 2019 Jun:133(6):e377-e384. doi: 10.1097/AOG.0000000000003271. Epub
[PubMed PMID: 31135764]
Level 3 (low-level) evidence
[3]
Recent advances in medically assisted conception. Report of a WHO Scientific Group. World Health Organization technical report series. 1992;
[PubMed PMID: 1642014]
Level 3 (low-level) evidence
[4]
Chandra A,Copen CE,Stephen EH, Infertility and impaired fecundity in the United States, 1982-2010: data from the National Survey of Family Growth. National health statistics reports. 2013 Aug 14;
[PubMed PMID: 24988820]
Level 3 (low-level) evidence
[5]
Mascarenhas MN,Flaxman SR,Boerma T,Vanderpoel S,Stevens GA, National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS medicine. 2012;
[PubMed PMID: 23271957]
Level 3 (low-level) evidence
[6]
Santoro N,Filicori M,Crowley WF Jr, Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. Endocrine reviews. 1986 Feb;
[PubMed PMID: 3082615]
[7]
Ackerman KE,Patel KT,Guereca G,Pierce L,Herzog DB,Misra M, Cortisol secretory parameters in young exercisers in relation to LH secretion and bone parameters. Clinical endocrinology. 2013 Jan;
[PubMed PMID: 22671919]
[8]
Perkins RB, Hall JE, Martin KA. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation. The Journal of clinical endocrinology and metabolism. 1999 Jun:84(6):1905-11
[PubMed PMID: 10372685]
[9]
Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 1987 Sep:1(3):235-45
[PubMed PMID: 3140583]
Level 2 (mid-level) evidence
[10]
Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human reproduction (Oxford, England). 2004 Jan:19(1):41-7
[PubMed PMID: 14688154]
Level 3 (low-level) evidence
[11]
Fauser BC,Van Heusden AM, Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocrine reviews. 1997 Feb;
[PubMed PMID: 9034787]
[12]
Baker TG. Radiosensitivity of mammalian oocytes with particular reference to the human female. American journal of obstetrics and gynecology. 1971 Jul 1:110(5):746-61
[PubMed PMID: 4935165]
[13]
Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. The Journal of clinical endocrinology and metabolism. 1987 Dec:65(6):1231-7
[PubMed PMID: 3119654]
[14]
Westhoff C, Murphy P, Heller D. Predictors of ovarian follicle number. Fertility and sterility. 2000 Oct:74(4):624-8
[PubMed PMID: 11020495]
[15]
Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocrine reviews. 2009 Aug:30(5):465-93. doi: 10.1210/er.2009-0006. Epub 2009 Jul 9
[PubMed PMID: 19589949]
[16]
Nelson LM,Anasti JN,Kimzey LM,Defensor RA,Lipetz KJ,White BJ,Shawker TH,Merino MJ, Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. The Journal of clinical endocrinology and metabolism. 1994 Nov;
[PubMed PMID: 7962345]
[17]
Nelson LM, Clinical practice. Primary ovarian insufficiency. The New England journal of medicine. 2009 Feb 5;
[PubMed PMID: 19196677]
[18]
Seppälä M, Ranta T, Hirvonen E. Hyperprolactinaemia and luteal insufficiency. Lancet (London, England). 1976 Jan 31:1(7953):229-30
[PubMed PMID: 55535]
[19]
Olive DL, Pritts EA. Treatment of endometriosis. The New England journal of medicine. 2001 Jul 26:345(4):266-75
[PubMed PMID: 11474666]
[20]
Prescott J, Farland LV, Tobias DK, Gaskins AJ, Spiegelman D, Chavarro JE, Rich-Edwards JW, Barbieri RL, Missmer SA. A prospective cohort study of endometriosis and subsequent risk of infertility. Human reproduction (Oxford, England). 2016 Jul:31(7):1475-82. doi: 10.1093/humrep/dew085. Epub 2016 May 1
[PubMed PMID: 27141041]
[21]
Macer ML,Taylor HS, Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstetrics and gynecology clinics of North America. 2012 Dec;
[PubMed PMID: 23182559]
[22]
Bulun SE. Endometriosis. The New England journal of medicine. 2009 Jan 15:360(3):268-79. doi: 10.1056/NEJMra0804690. Epub
[PubMed PMID: 19144942]
[23]
Gupta S,Goldberg JM,Aziz N,Goldberg E,Krajcir N,Agarwal A, Pathogenic mechanisms in endometriosis-associated infertility. Fertility and sterility. 2008 Aug;
[PubMed PMID: 18672121]
[25]
Toya M, Saito H, Ohta N, Saito T, Kaneko T, Hiroi M. Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer. Fertility and sterility. 2000 Feb:73(2):344-50
[PubMed PMID: 10685541]
[26]
Weström L,Joesoef R,Reynolds G,Hagdu A,Thompson SE, Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sexually transmitted diseases. 1992 Jul-Aug;
[PubMed PMID: 1411832]
[27]
Weström L, Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. American journal of obstetrics and gynecology. 1980 Dec 1;
[PubMed PMID: 7008604]
[28]
Lepine LA,Hillis SD,Marchbanks PA,Joesoef MR,Peterson HB,Westrom L, Severity of pelvic inflammatory disease as a predictor of the probability of live birth. American journal of obstetrics and gynecology. 1998 May;
[PubMed PMID: 9609570]
[29]
Meyer WR, Castelbaum AJ, Somkuti S, Sagoskin AW, Doyle M, Harris JE, Lessey BA. Hydrosalpinges adversely affect markers of endometrial receptivity. Human reproduction (Oxford, England). 1997 Jul:12(7):1393-8
[PubMed PMID: 9262264]
[30]
Van Voorhis BJ, Mejia RB, Schlaff WD, Hurst BS. Is removal of hydrosalpinges prior to in vitro fertilization the standard of care? Fertility and sterility. 2019 Apr:111(4):652-656. doi: 10.1016/j.fertnstert.2019.02.015. Epub
[PubMed PMID: 30929723]
[31]
Pritts EA, Fibroids and infertility: a systematic review of the evidence. Obstetrical
[PubMed PMID: 11496160]
Level 1 (high-level) evidence
[32]
Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Human reproduction update. 2001 Mar-Apr:7(2):161-74
[PubMed PMID: 11284660]
[33]
Chan YY, Jayaprakasan K, Zamora J, Thornton JG, Raine-Fenning N, Coomarasamy A. The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review. Human reproduction update. 2011 Nov-Dec:17(6):761-71. doi: 10.1093/humupd/dmr028. Epub 2011 Jun 24
[PubMed PMID: 21705770]
Level 1 (high-level) evidence
[34]
Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertility and sterility. 2013 Jan:99(1):63. doi: 10.1016/j.fertnstert.2012.09.023. Epub 2012 Oct 22
[PubMed PMID: 23095139]
Level 3 (low-level) evidence
[36]
Wathen NC, Perry L, Lilford RJ, Chard T. Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. British medical journal (Clinical research ed.). 1984 Jan 7:288(6410):7-9
[PubMed PMID: 6418326]
[37]
Ecochard R, Boehringer H, Rabilloud M, Marret H. Chronological aspects of ultrasonic, hormonal, and other indirect indices of ovulation. BJOG : an international journal of obstetrics and gynaecology. 2001 Aug:108(8):822-9
[PubMed PMID: 11510707]
[38]
Abdalla H,Thum MY, An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Human reproduction (Oxford, England). 2004 Apr;
[PubMed PMID: 15016786]
Level 2 (mid-level) evidence
[39]
Smotrich DB, Widra EA, Gindoff PR, Levy MJ, Hall JL, Stillman RJ. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertility and sterility. 1995 Dec:64(6):1136-40
[PubMed PMID: 7589666]
[40]
Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA. The physiology and clinical utility of anti-Mullerian hormone in women. Human reproduction update. 2014 May-Jun:20(3):370-85. doi: 10.1093/humupd/dmt062. Epub 2014 Jan 14
[PubMed PMID: 24430863]
[41]
de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertility and sterility. 2002 Feb:77(2):357-62
[PubMed PMID: 11821097]
[42]
Toner JP, Seifer DB. Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimüllerian hormone. Fertility and sterility. 2013 Jun:99(7):1825-30. doi: 10.1016/j.fertnstert.2013.03.001. Epub 2013 Mar 30
[PubMed PMID: 23548941]
[43]
Steiner AZ,Pritchard D,Stanczyk FZ,Kesner JS,Meadows JW,Herring AH,Baird DD, Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. JAMA. 2017 Oct 10;
[PubMed PMID: 29049585]
[44]
Vrontikis A, Chang PL, Kovacs P, Lindheim SR. Antral follice counts (AFC) predict ovarian response and pregnancy outcomes in oocyte donation cycles. Journal of assisted reproduction and genetics. 2010 Jul:27(7):383-9. doi: 10.1007/s10815-010-9421-8. Epub 2010 May 14
[PubMed PMID: 20467804]
[45]
Mol BW, Swart P, Bossuyt PM, van der Veen F. Is hysterosalpingography an important tool in predicting fertility outcome? Fertility and sterility. 1997 Apr:67(4):663-9
[PubMed PMID: 9093191]
[46]
Papaioannou S,Bourdrez P,Varma R,Afnan M,Mol BW,Coomarasamy A, Tubal evaluation in the investigation of subfertility: a structured comparison of tests. BJOG : an international journal of obstetrics and gynaecology. 2004 Dec;
[PubMed PMID: 15663113]
[47]
Luttjeboer F, Harada T, Hughes E, Johnson N, Lilford R, Mol BW. Tubal flushing for subfertility. The Cochrane database of systematic reviews. 2007 Jul 18:(3):CD003718
[PubMed PMID: 17636730]
Level 1 (high-level) evidence
[48]
Seshadri S, El-Toukhy T, Douiri A, Jayaprakasan K, Khalaf Y. Diagnostic accuracy of saline infusion sonography in the evaluation of uterine cavity abnormalities prior to assisted reproductive techniques: a systematic review and meta-analyses. Human reproduction update. 2015 Mar-Apr:21(2):262-74. doi: 10.1093/humupd/dmu057. Epub 2014 Dec 10
[PubMed PMID: 25505226]
Level 1 (high-level) evidence
[49]
Frisch RE, The right weight: body fat, menarche and ovulation. Bailliere's clinical obstetrics and gynaecology. 1990 Sep;
[PubMed PMID: 2282736]
[50]
Yen SS,Rebar R,Vandenberg G,Ehara Y,Siler T, Pituitary gonadotrophin responsiveness to synthetic LRF in subjects with normal and abnormal hypothalamic-pituitary-gonadal axis. Journal of reproduction and fertility. Supplement. 1973 Dec;
[PubMed PMID: 4599401]
[51]
Abraham S, Mira M, Llewellyn-Jones D. Should ovulation be induced in women recovering from an eating disorder or who are compulsive exercisers? Fertility and sterility. 1990 Mar:53(3):566-8
[PubMed PMID: 2407567]
[52]
Berga SL, Marcus MD, Loucks TL, Hlastala S, Ringham R, Krohn MA. Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy. Fertility and sterility. 2003 Oct:80(4):976-81
[PubMed PMID: 14556820]
[53]
Crosignani PG,Colombo M,Vegetti W,Somigliana E,Gessati A,Ragni G, Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Human reproduction (Oxford, England). 2003 Sep;
[PubMed PMID: 12923151]
[54]
Mutsaerts MA, van Oers AM, Groen H, Burggraaff JM, Kuchenbecker WK, Perquin DA, Koks CA, van Golde R, Kaaijk EM, Schierbeek JM, Oosterhuis GJ, Broekmans FJ, Bemelmans WJ, Lambalk CB, Verberg MF, van der Veen F, Klijn NF, Mercelina PE, van Kasteren YM, Nap AW, Brinkhuis EA, Vogel NE, Mulder RJ, Gondrie ET, de Bruin JP, Sikkema JM, de Greef MH, ter Bogt NC, Land JA, Mol BW, Hoek A. Randomized Trial of a Lifestyle Program in Obese Infertile Women. The New England journal of medicine. 2016 May 19:374(20):1942-53. doi: 10.1056/NEJMoa1505297. Epub
[PubMed PMID: 27192672]
Level 1 (high-level) evidence
[55]
Wu CH, Winkel CA. The effect of therapy initiation day on clomiphene citrate therapy. Fertility and sterility. 1989 Oct:52(4):564-8
[PubMed PMID: 2806595]
[56]
Cole PA, Robinson CH. Mechanism and inhibition of cytochrome P-450 aromatase. Journal of medicinal chemistry. 1990 Nov:33(11):2933-42
[PubMed PMID: 2231592]
[57]
. ACOG Committee Opinion No. 738: Aromatase Inhibitors in Gynecologic Practice. Obstetrics and gynecology. 2018 Jun:131(6):1. doi: 10.1097/AOG.0000000000002640. Epub
[PubMed PMID: 29794680]
Level 3 (low-level) evidence
[58]
Casper RF, Mitwally MF. Review: aromatase inhibitors for ovulation induction. The Journal of clinical endocrinology and metabolism. 2006 Mar:91(3):760-71
[PubMed PMID: 16384846]
[59]
Weiss NS, Nahuis MJ, Bordewijk E, Oosterhuis JE, Smeenk JM, Hoek A, Broekmans FJ, Fleischer K, de Bruin JP, Kaaijk EM, Laven JS, Hendriks DJ, Gerards MH, van Rooij IA, Bourdrez P, Gianotten J, Koks C, Lambalk CB, Hompes PG, van der Veen F, Mol BWJ, van Wely M. Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial. Lancet (London, England). 2018 Feb 24:391(10122):758-765. doi: 10.1016/S0140-6736(17)33308-1. Epub 2017 Dec 19
[PubMed PMID: 29273245]
Level 1 (high-level) evidence
[60]
Ludwig M, Doody KJ, Doody KM. Use of recombinant human chorionic gonadotropin in ovulation induction. Fertility and sterility. 2003 May:79(5):1051-9
[PubMed PMID: 12738494]
[61]
Cantineau AE, Janssen MJ, Cohlen BJ. Synchronised approach for intrauterine insemination in subfertile couples. The Cochrane database of systematic reviews. 2010 Apr 14:(4):CD006942. doi: 10.1002/14651858.CD006942.pub2. Epub 2010 Apr 14
[PubMed PMID: 20393953]
Level 1 (high-level) evidence
[62]
Johnson NP, Mak W, Sowter MC. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. The Cochrane database of systematic reviews. 2004:(3):CD002125
[PubMed PMID: 15266464]
Level 1 (high-level) evidence
[63]
Audebert A,Pouly JL,Bonifacie B,Yazbeck C, Laparoscopic surgery for distal tubal occlusions: lessons learned from a historical series of 434 cases. Fertility and sterility. 2014 Oct;
[PubMed PMID: 25150389]
Level 3 (low-level) evidence
[64]
Boeckxstaens A, Devroey P, Collins J, Tournaye H. Getting pregnant after tubal sterilization: surgical reversal or IVF? Human reproduction (Oxford, England). 2007 Oct:22(10):2660-4
[PubMed PMID: 17670765]
[65]
Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertility and sterility. 2009 Apr:91(4):1215-23. doi: 10.1016/j.fertnstert.2008.01.051. Epub 2008 Mar 12
[PubMed PMID: 18339376]
Level 1 (high-level) evidence
[66]
Casini ML,Rossi F,Agostini R,Unfer V, Effects of the position of fibroids on fertility. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2006 Feb
[PubMed PMID: 16603437]
Level 2 (mid-level) evidence
[67]
March CM, Israel R. Gestational outcome following hysteroscopic lysis of adhesions. Fertility and sterility. 1981 Oct:36(4):455-9
[PubMed PMID: 6269905]
[68]
Pérez-Medina T,Bajo-Arenas J,Salazar F,Redondo T,Sanfrutos L,Alvarez P,Engels V, Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study. Human reproduction (Oxford, England). 2005 Jun;
[PubMed PMID: 15760959]
Level 1 (high-level) evidence
[69]
Milczarek M, Kucharska A, Borowiec A. Difficulties in diagnostics of polycystic ovary syndrome in adolescents - a preliminary study. Pediatric endocrinology, diabetes, and metabolism. 2019:25(3):122-126. doi: 10.5114/pedm.2019.87177. Epub
[PubMed PMID: 31769270]
[70]
Derksen J, Nagesser SK, Meinders AE, Haak HR, van de Velde CJ. Identification of virilizing adrenal tumors in hirsute women. The New England journal of medicine. 1994 Oct 13:331(15):968-73
[PubMed PMID: 8084355]
[71]
Azziz R, Dewailly D, Owerbach D. Clinical review 56: Nonclassic adrenal hyperplasia: current concepts. The Journal of clinical endocrinology and metabolism. 1994 Apr:78(4):810-5
[PubMed PMID: 8157702]
[72]
Zolton JR, Lindner PG, Terry N, DeCherney AH, Hill MJ. Gonadotropins versus oral ovarian stimulation agents for unexplained infertility: a systematic review and meta-analysis. Fertility and sterility. 2020 Feb:113(2):417-425.e1. doi: 10.1016/j.fertnstert.2019.09.042. Epub 2020 Jan 20
[PubMed PMID: 31973903]
Level 1 (high-level) evidence
[73]
Liu A, Zheng C, Lang J, Chen W. Letrozole versus clomiphene citrate for unexplained infertility: a systematic review and meta-analysis. The journal of obstetrics and gynaecology research. 2014 May:40(5):1205-16. doi: 10.1111/jog.12393. Epub
[PubMed PMID: 24754848]
Level 1 (high-level) evidence
[74]
Reindollar RH,Regan MM,Neumann PJ,Levine BS,Thornton KL,Alper MM,Goldman MB, A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertility and sterility. 2010 Aug;
[PubMed PMID: 19531445]
Level 1 (high-level) evidence
[75]
Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in infertile women: a committee opinion. Fertility and sterility. 2013 Aug:100(2):341-8. doi: 10.1016/j.fertnstert.2013.05.033. Epub 2013 Jun 27
[PubMed PMID: 23809505]
Level 3 (low-level) evidence
[76]
Sunderam S,Kissin DM,Zhang Y,Folger SG,Boulet SL,Warner L,Callaghan WM,Barfield WD, Assisted Reproductive Technology Surveillance - United States, 2016. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002). 2019 Apr 26;
[PubMed PMID: 31022165]
[77]
Yu B, Vega M, Zaghi S, Fritz R, Jindal S, Buyuk E. Comparison of perinatal outcomes following frozen embryo transfer cycles using autologous versus donor oocytes in women 40 to 43 years old: analysis of SART CORS data. Journal of assisted reproduction and genetics. 2018 Nov:35(11):2025-2029. doi: 10.1007/s10815-018-1287-1. Epub 2018 Aug 20
[PubMed PMID: 30128819]
[78]
Hansen KR,He AL,Styer AK,Wild RA,Butts S,Engmann L,Diamond MP,Legro RS,Coutifaris C,Alvero R,Robinson RD,Casson P,Christman GM,Huang H,Santoro N,Eisenberg E,Zhang H, Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination. Fertility and sterility. 2016 Jun;
[PubMed PMID: 26949110]
[79]
Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the Society for Assisted Reproductive Technology. Guidance on the limits to the number of embryos to transfer: a committee opinion. Fertility and sterility. 2017 Apr:107(4):901-903. doi: 10.1016/j.fertnstert.2017.02.107. Epub 2017 Mar 11
[PubMed PMID: 28292618]
Level 3 (low-level) evidence
[80]
Li C, Zhao WH, Zhu Q, Cao SJ, Ping H, Xi X, Qin GJ, Yan MX, Zhang D, Qiu J, Zhang J. Risk factors for ectopic pregnancy: a multi-center case-control study. BMC pregnancy and childbirth. 2015 Aug 22:15():187. doi: 10.1186/s12884-015-0613-1. Epub 2015 Aug 22
[PubMed PMID: 26296545]
Level 2 (mid-level) evidence
[81]
Londra L,Moreau C,Strobino D,Garcia J,Zacur H,Zhao Y, Ectopic pregnancy after in vitro fertilization: differences between fresh and frozen-thawed cycles. Fertility and sterility. 2015 Jul;
[PubMed PMID: 25956363]
[82]
Diamond MP,Legro RS,Coutifaris C,Alvero R,Robinson RD,Casson P,Christman GM,Ager J,Huang H,Hansen KR,Baker V,Usadi R,Seungdamrong A,Bates GW,Rosen RM,Haisenleder D,Krawetz SA,Barnhart K,Trussell JC,Ohl D,Jin Y,Santoro N,Eisenberg E,Zhang H, Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility. The New England journal of medicine. 2015 Sep 24;
[PubMed PMID: 26398071]
[83]
Golan A,Ron-el R,Herman A,Soffer Y,Weinraub Z,Caspi E, Ovarian hyperstimulation syndrome: an update review. Obstetrical
[PubMed PMID: 2660037]
[84]
Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Human reproduction update. 2002 Nov-Dec:8(6):559-77
[PubMed PMID: 12498425]